Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Yuantong Pharmaceutical is a prominent pharmaceutical commercial enterprise and a key subsidiary of the Sichuan Kelun Pharmaceutical Group. Based in Chengdu, China, the company focuses on the wholesale distribution, logistics, and sales of a diverse range of healthcare products, including large-volume injections, small-volume injections, and various finished dosage forms. It serves as the primary commercial arm for the Kelun Group, managing the market reach and supply chain for both internal products and third-party medical supplies. The company operates extensive GSP-certified warehousing and distribution networks, supporting the healthcare infrastructure across Southwest China and beyond. By leveraging the manufacturing strength of its parent company, Yuantong ensures the efficient delivery of essential medicines to hospitals and pharmacies. Its operations are central to the commercial strategy of one of China's largest pharmaceutical conglomerates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Yuanton Pharmaceutical.